45 CFR § 180 compliance
A · 100
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,631
Insurances with rates
7
CPT / HCPCS codes
2,430
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $238,702 | $169,478 | $169,478 | $226,767 | 5 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $238,702 | $169,478 | $169,478 | $236,315 | 10 |
| C1721 | DEFIB CURRENT DR 36J 2207-36 | $80,520 | $57,169 | $57,169 | $76,494 | 5 |
| C1721 | DEFIB CURRENT DR 36J 2207-36 | $80,520 | $57,169 | $57,169 | $79,715 | 10 |
| C1772 | DEFIBRILLATOR EMBLEM MRI S-ICD | $69,540 | $49,373 | $49,373 | $66,063 | 5 |
| C1772 | DEFIBRILLATOR EMBLEM MRI S-ICD | $69,540 | $49,373 | $49,373 | $68,845 | 10 |
| A9513 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $47,500 | $33,725 | $33,725 | $45,125 | 5 |
| A9513 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $47,500 | $33,725 | $314 | $47,025 | 11 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $41,580 | $29,522 | $29,522 | $39,501 | 5 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $41,580 | $29,522 | $29,522 | $41,164 | 10 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $41,174 | $29,234 | $29,234 | $39,115 | 5 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $41,174 | $29,234 | $432 | $40,762 | 11 |
| L8681 | CHARGER OMNIA PATIENT REMOTE HF10C | $40,250 | $28,578 | $28,578 | $38,238 | 5 |
| L8681 | CHARGER OMNIA PATIENT REMOTE HF10C | $40,250 | $28,578 | $28,578 | $39,848 | 10 |
| C1817 | AMPLATZER CARDIAC PLUG 25MM 9-ACP2-007-025 | $35,640 | $25,304 | $25,304 | $33,858 | 5 |
| C1817 | AMPLATZER CARDIAC PLUG 25MM 9-ACP2-007-025 | $35,640 | $25,304 | $25,304 | $35,284 | 10 |
| L8687 | GENRTR IMP PULSE MRI PRODIGY 3772 CONTROLSYS | $29,750 | $21,123 | $21,123 | $28,263 | 5 |
| L8687 | GENRTR IMP PULSE MRI PRODIGY 3772 CONTROLSYS | $29,750 | $21,123 | $21,123 | $29,453 | 10 |
| C1882 | BIV AICE UNIFY ASSURA CD3357-40C | $28,181 | $20,009 | $20,009 | $26,772 | 5 |
| C1882 | BIV AICE UNIFY ASSURA CD3357-40C | $28,181 | $20,009 | $20,009 | $27,899 | 10 |
| L8614 | ELCTRD PROFLE NUCMODIOLAR SLIM P783831 | $27,450 | $19,490 | $19,490 | $26,078 | 5 |
| L8614 | ELCTRD PROFLE NUCMODIOLAR SLIM P783831 | $27,450 | $19,490 | $19,490 | $27,176 | 10 |
| C1757 | ARTIX FLWTRVR RETRIEVAL ASPIR ARTIX-PPP | $27,450 | $19,490 | $19,490 | $26,078 | 5 |
| C1757 | ARTIX FLWTRVR RETRIEVAL ASPIR ARTIX-PPP | $27,450 | $19,490 | $19,490 | $27,176 | 10 |
| C1722 | DEFIB CARD LUMAX 740 VR-T DX 372419 | $27,300 | $19,383 | $19,383 | $25,935 | 5 |
| C1722 | DEFIB CARD LUMAX 740 VR-T DX 372419 | $27,300 | $19,383 | $19,383 | $27,027 | 10 |
| C1813 | CYL AMBICOR 11MMX16CM 72401451 | $26,590 | $18,879 | $18,879 | $25,261 | 5 |
| C1813 | CYL AMBICOR 11MMX16CM 72401451 | $26,590 | $18,879 | $18,879 | $26,324 | 10 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $24,191 | $17,175 | $17,175 | $22,981 | 5 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $24,191 | $17,175 | $340 | $23,949 | 11 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $22,602 | $16,047 | $16,047 | $21,472 | 5 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $22,602 | $16,047 | $3,868 | $22,376 | 11 |
| Q4116 | ALLDERM RESTORE LG PERF MED RL1518P | $22,045 | $15,652 | $15,652 | $20,943 | 5 |
| Q4116 | ALLDERM RESTORE LG PERF MED RL1518P | $22,045 | $15,652 | $15,652 | $21,825 | 10 |
| J2327 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE | $21,600 | $15,336 | $15,336 | $20,520 | 5 |
| J2327 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE | $21,600 | $15,336 | $15,336 | $21,384 | 10 |
| C2621 | BIV PPM CONSULTA CRT-P C4TR01 | $21,499 | $15,264 | $15,264 | $20,424 | 5 |
| C2621 | BIV PPM CONSULTA CRT-P C4TR01 | $21,499 | $15,264 | $15,264 | $21,284 | 10 |
| C1896 | ELECTRD Q TRAK 3400 | $18,300 | $12,993 | $12,993 | $17,385 | 5 |
| C1896 | ELECTRD Q TRAK 3400 | $18,300 | $12,993 | $12,993 | $18,117 | 10 |
| J1930 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $18,300 | $12,993 | $12,993 | $17,385 | 5 |
| J1930 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $18,300 | $12,993 | $42.91 | $18,117 | 11 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $18,069 | $12,829 | $12,829 | $17,166 | 5 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $18,069 | $12,829 | $144 | $17,889 | 11 |
| C1821 | IMP COFLEX SZ 10 UQI00010 | $17,568 | $12,473 | $12,473 | $16,690 | 5 |
| C1821 | IMP COFLEX SZ 10 UQI00010 | $17,568 | $12,473 | $12,473 | $17,392 | 10 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $17,124 | $12,158 | $12,158 | $16,268 | 5 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $17,124 | $12,158 | $148 | $16,952 | 11 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $15,472 | $10,985 | $10,985 | $14,698 | 5 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $15,472 | $10,985 | $383 | $15,317 | 11 |
Showing top 50 of 2,631 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.